Callan Family Office, LLC
Family OfficePosition in DGX — Quest Diagnostics Inc
CIK 1938970
RADNOR, PA
Position in DGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,243,722
+$71,958 QoQ
Shares Held
5,868
-1.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#453
of 1,090 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Callan Family Office, LLC holds $27,416,772 across 17 Diagnostics & Research names. DGX ranks #7 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
16,644 | $8,344,635 | |
| 2 | DHR |
Danaher Corp /De/
|
20,031 | $3,815,504 | |
| 3 | A |
Agilent Technologies, Inc.
|
16,725 | $2,221,581 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
3,531 | $1,858,859 | |
| 5 | ILMN |
Illumina, Inc.
|
10,254 | $1,802,960 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
9,044 | $1,747,481 | |
| 7 | DGX |
Quest Diagnostics Inc
This page
|
5,868 | $1,243,722 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
902 | $1,152,314 |
All Filings in DGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,243,722 | 5,868 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,171,764 | 5,979 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,255,142 | 7,233 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $440,049 | 2,309 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $619,184 | 3,447 | Shares | Sole | 2025-07-24 | |
| 2024-12-31 | $203,510 | 1,349 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||